While CAR-T cell therapies have been a promising new area of cancer treatments, they are costly to produce, have had limited success in treating solid tumors, and can carry sometimes serious side effects. Shoreline Biosciences is developing off-the-shelf natural killer and macrophage cellular immunotherapies derived from induced pluripotent stem cells for cancer, inflammatory, and genetic […]

Obsidian Therapeutics is targeting oncologic indications with cell and gene therapies developed with the use of their cytoDRIVE platform. Their lead program, cytoTIL15, is a tumor-infiltrating lymphocyte (TIL) therapy in investigational new drug (IND)-enabling studies for melanoma as well as preclinical studies for head and neck squamous cell carcinomas and discovery phases for other oncologic […]

Imagine surviving cancer and then getting a new chronic disease as a side effect of treatment. That’s reality for cancer survivors who develop the limb-swelling complication lymphedema, which is caused by a buildup of lymphatic fluid. But as medical device maker ImpediMed points out in its first major consumer-facing campaign, testing and early detection can […]